AB Sciex, Univ. of Melbourne to Develop Mass Spec Approach for Metabolism Studies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AB Sciex today announced a collaboration with researchers at the University of Melbourne to develop standardized testing methodologies for the study of biopharmaceutical metabolism.

The project will be based on an approach developed by scientists at the university on the AB Sciex QTrap 5500 system to evaluate how protein-based drugs break down in vivo, something that drug discovery researchers currently cannot do.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.